Medigen Biotechnology (3176) — Net Asset Quality Index
Medigen Biotechnology (3176) has a Net Asset Quality Index of 77.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$6.34 Billion minus total liabilities of NT$1.45 Billion yields net assets of NT$4.90 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Medigen Biotechnology debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Medigen Biotechnology Net Asset Quality Index Over Time (2003–2024)
This chart shows how Medigen Biotechnology's Net Asset Quality Index has evolved across 22 annual periods from 2003 to 2024. As of September 2025, the index stands at 77.2%, representing net assets of NT$4.90 Billion against total assets of NT$6.34 Billion TWD. For live market cap and overall valuation, see 3176 market cap overview.
Annual Net Asset Quality Index for Medigen Biotechnology (2003–2024)
The table below presents the year-by-year Net Asset Quality Index for Medigen Biotechnology from 2003 to 2024, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check strategic asset allocation of Medigen Biotechnology to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 75.1% | NT$5.04 Billion | NT$6.71 Billion | NT$1.67 Billion | ▲ +16.5 pp |
| 2023 | 58.6% | NT$5.00 Billion | NT$8.53 Billion | NT$3.53 Billion | ▼ -6.2 pp |
| 2022 | 64.8% | NT$6.47 Billion | NT$9.98 Billion | NT$3.51 Billion | ▼ -13.5 pp |
| 2021 | 78.4% | NT$6.43 Billion | NT$8.20 Billion | NT$1.77 Billion | ▲ +5.2 pp |
| 2020 | 73.1% | NT$4.50 Billion | NT$6.15 Billion | NT$1.65 Billion | ▲ +17.5 pp |
| 2019 | 55.6% | NT$2.69 Billion | NT$4.83 Billion | NT$2.14 Billion | ▼ -8.3 pp |
| 2018 | 64.0% | NT$2.94 Billion | NT$4.60 Billion | NT$1.66 Billion | ▼ -1.3 pp |
| 2017 | 65.3% | NT$3.18 Billion | NT$4.87 Billion | NT$1.69 Billion | ▼ -8.1 pp |
| 2016 | 73.4% | NT$3.54 Billion | NT$4.82 Billion | NT$1.28 Billion | ▼ -3.7 pp |
| 2015 | 77.1% | NT$3.46 Billion | NT$4.49 Billion | NT$1.03 Billion | ▼ -4.9 pp |
| 2014 | 82.0% | NT$3.66 Billion | NT$4.46 Billion | NT$804.40 Million | ▼ -11.1 pp |
| 2013 | 93.1% | NT$3.07 Billion | NT$3.29 Billion | NT$226.84 Million | ▲ +1.4 pp |
| 2012 | 91.7% | NT$2.05 Billion | NT$2.24 Billion | NT$186.42 Million | ▲ +16.3 pp |
| 2011 | 75.4% | NT$915.79 Million | NT$1.21 Billion | NT$298.81 Million | ▼ -17.5 pp |
| 2010 | 92.9% | NT$807.90 Million | NT$869.78 Million | NT$61.88 Million | ▲ +5.0 pp |
| 2009 | 87.9% | NT$597.02 Million | NT$679.27 Million | NT$82.25 Million | ▲ +8.6 pp |
| 2008 | 79.2% | NT$539.65 Million | NT$680.98 Million | NT$141.33 Million | ▲ +0.2 pp |
| 2007 | 79.0% | NT$468.68 Million | NT$593.03 Million | NT$124.35 Million | ▼ -10.9 pp |
| 2006 | 89.9% | NT$667.93 Million | NT$742.89 Million | NT$74.96 Million | ▼ -2.7 pp |
| 2005 | 92.6% | NT$650.39 Million | NT$702.17 Million | NT$51.78 Million | ▼ -3.7 pp |
| 2004 | 96.3% | NT$739.26 Million | NT$767.53 Million | NT$28.26 Million | ▲ +7.7 pp |
| 2003 | 88.6% | NT$856.65 Million | NT$966.81 Million | NT$110.16 Million | — |